EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Population Pharmacokinetic Analyses and Exposure–Efficacy Relationships of Venetoclax in Chinese Pediatric Patients with Hematological Malignancy in a Real‐World Setting

Yinyu Zhao, Xuchen Song, Lin Zhang, Yidan Zhu, Jiali Chen, Yiru Gong, Xingxian Luo, Huan He, Xiaohong Zhang, Lin Huang iD

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s583847 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Yinyu Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Peking University People's Hospital, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Bridged Bicyclo Compounds, Heterocyclic, Hematologic Neoplasms, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsBridged Bicyclo Compounds, HeterocyclicHematologic NeoplasmsLeukemia, Myeloid, AcuteSulfonamidesAdolescentChildChild, PreschoolFemaleHumansInfantMaleChinaDose-Response Relationship, DrugRetrospective StudiesEast Asian People

Stichwörter der Autor:innen

hematological malignancypediatricpopulation pharmacokineticsvenetoclax

Substanzen

Antineoplastic AgentsBridged Bicyclo Compounds, HeterocyclicSulfonamidesvenetoclax

Autor:innen und Institutionen

  • Department of Pharmacy, Peking University People's Hospital, Beijing, People's Republic of China.
  • School of Pharmaceutical Sciences, Peking University, Beijing, People's Republic of China.
  • School of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, People's Republic of China.
  • Department of Pediatrics, Peking University People's Hospital, Beijing, People's Republic of China.
  • Department of Pharmacy, Beijing Children's Hospital of Capital Medical University, Beijing, People's Republic of China.

ORCID-Profile: Lin Huang

Zitieren

APA

Zhao, Y., Song, X., Zhang, L., Zhu, Y., Chen, J., Gong, Y., Luo, X., He, H., Zhang, X., & Huang, L. (2026). Population Pharmacokinetic Analyses and Exposure–Efficacy Relationships of Venetoclax in Chinese Pediatric Patients with Hematological Malignancy in a Real‐World Setting. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s583847

Vancouver

Zhao Y, Song X, Zhang L, Zhu Y, Chen J, Gong Y, et al. Population Pharmacokinetic Analyses and Exposure–Efficacy Relationships of Venetoclax in Chinese Pediatric Patients with Hematological Malignancy in a Real‐World Setting. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s583847

BibTeX
@article{Zhao2026,
  author = {Zhao, Yinyu and Song, Xuchen and Zhang, Lin and Zhu, Yidan and Chen, Jiali and Gong, Yiru and Luo, Xingxian and He, Huan and Zhang, Xiaohong and Huang, Lin},
  title = {Population Pharmacokinetic Analyses and Exposure–Efficacy Relationships of Venetoclax in Chinese Pediatric Patients with Hematological Malignancy in a Real‐World Setting},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s583847}
}
Kostenlos starten →